Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021

Rhea-AI Summary

Generation Bio Co. (Nasdaq: GBIO) announces participation of CEO Geoff McDonough, M.D., in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021 on August 10 at 9:10 a.m. ET. The event will focus on the company's innovations in genetic medicines for rare and prevalent diseases. A live webcast will be available on the company's investor website, with a replay accessible for 30 days post-event. Generation Bio's unique platform, utilizing closed-ended DNA and advanced lipid nanoparticle delivery, aims to provide durable treatments and scalable manufacturing for genetic therapies.

CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced today that Geoff McDonough, M.D., president and chief executive officer, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021 on Tuesday, August 10 at 9:10 a.m. ET. 

A live webcast of the panel will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.

About Generation Bio

Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral platform incorporates a novel DNA construct called closed-ended DNA, or ceDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly scalable capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, or RES, to produce ceDNA. The platform is designed to enable multi-year durability from a single dose, to deliver large genetic payloads, including multiple genes, to specific tissues, and to allow titration and redosing to adjust or extend expression levels in each patient. RES has the potential to expand Generation Bio’s manufacturing scale to hundreds of millions of doses to support its mission to extend the reach of genetic medicine to more people, living with more diseases, around the world.

For more information, please visit www.generationbio.com.

Contact:

Investors 
Maren Killackey
Generation Bio
mkillackey@generationbio.com
541-646-2420

Media 
Alicia Webb
Generation Bio
awebb@generationbio.com
847-254-4275

Stephanie Simon 
Ten Bridge Communications
stephanie@tenbridgecommunications.com
617-581-9333

 

FAQ

When is Generation Bio's CEO participating in the Wedbush PacGrow Healthcare Conference?

Geoff McDonough, CEO of Generation Bio, will participate in the Wedbush PacGrow Healthcare Conference on August 10, 2021, at 9:10 a.m. ET.

How can I watch the Wedbush PacGrow Healthcare Conference panel discussion for Generation Bio?

The panel discussion will be available via a live webcast on Generation Bio's investor website.

What is Generation Bio's focus in the biotechnology sector?

Generation Bio focuses on innovating genetic medicines for patients with rare and prevalent diseases.

What technologies does Generation Bio utilize in its genetic medicine platform?

Generation Bio's platform incorporates closed-ended DNA (ceDNA), cell-targeted lipid nanoparticles (ctLNP), and a proprietary cell-free rapid enzymatic synthesis (RES) process.

How long is the replay available after the conference for Generation Bio?

A replay of the panel discussion will be available for 30 days following the event.